265 results on '"polyneuropathies"'
Search Results
2. A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (VITALIZE)
3. Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System (Prompark)
4. Daratumumab for Polyneuropathy Associated With MGUS (Dara-MGUS)
5. Driving with Neuropathy
6. NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
7. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
8. Study for the Evaluation of the Degree of Skin Satisfaction of a Cosmetic Cream for Sensitive Skin in Oncological Patients Affected by a Palmoplantar Polyneuropathy Secondary to Chemotherapy.
9. A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work (MOBILIZE)
10. Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS) (PTA-DFS)
11. Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
12. Observational Study of Neurofilament Light Chain (NfL) as a Biomarker in Asymptomatic Carriers of the Transthyretin (TTR) Variants and Patients With Hereditary Transthyretin-mediated (hATTR) Amyloidosis With Polyneuropathy
13. Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
14. Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
15. Hizentra® in Inflammatory Neuropathies - pHeNIx Study (pHeNIx)
16. Two Dose Levels of Privigen in Pediatric CIDP
17. A Phase 3 Study of NTLA-2001 in ATTRv-PN
18. A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy
19. Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (IVITOC)
20. Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (ReCIX)
21. To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
22. Effect of Gluten-Free Dietary Education and Intraneural Facilitation® Therapy on Quality of Life in People With Diabetic Neuropathy
23. A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
24. Registry for Adults With Plasma Cell Disorders (PCD's)
25. Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
26. Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy
27. Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Patients with Cervical Lead Placement
28. IVIG Vs SCIG in CIDP
29. Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy
30. CPAx: Responsiveness and Minimal Clinically Important Difference
31. IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies
32. A Study to Assess Adults with CIDP Transitioning from IVIg to Efgartigimod PH20 SC
33. Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy (HiPPo)
34. Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (SCIG)
35. TRAMmoniTTR Study Genetic Screening of an At-risk Population for HATTR and Monitoring of TTR Positive Subjects (TRAMmoniTTR)
36. Development and Validation of the FBIndex to Determine the Risk of Falls for Patients with Neuromuscular Disorders (FBIndex)
37. Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia (LOCUS)
38. Efficacy and Safety of AG10 in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)
39. Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)
40. The Effect of Alpha Lipoid Acid and Vitamin B Preparation on Diabetic Polyneuropathy in Type 2 Diabetes Mellitus Patient
41. Effect of Exercise and Surgical Weight Loss on Polyneuropathy
42. Neuromuscular Electrical Stimulation For The Treatment of Diabetic Neuropathy (NMES-DN)
43. A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
44. Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy
45. A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) (ADHERE)
46. hATTR Polyneuropathy in Russia (PRIMER)
47. Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
48. Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (EMDA CIDP)
49. Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy (MAGNAZ)
50. Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.